Cargando…

The Impact of Withdrawal of Maintenance Immunosuppression and Graft Nephrectomy on HLA Sensitization and Calculated Chance of Future Transplant

BACKGROUND: The development of HLA antibodies towards a failing renal allograft is a barrier to retransplantation. This study aimed to compare the formation of HLA donor-specific antibodies (DSA) in patients undergoing graft nephrectomy and in those with a failed graft left in situ who had maintenan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nimmo, Ailish M. S. A., McIntyre, Sophie, Turner, David M., Henderson, Lorna K., Battle, Richard K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2018
Materias:	Kidney Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283087/ https://www.ncbi.nlm.nih.gov/pubmed/30584590 http://dx.doi.org/10.1097/TXD.0000000000000848

Ejemplares similares

The Privilege of Induction Avoidance and Calcineurin Inhibitors Withdrawal in 2 Haplotype HLA Matched White Kidney Transplantation
por: Brifkani, Zaid, et al.
Publicado: (2017)

Early Steroid Withdrawal Compared With Standard Immunosuppression in Kidney Transplantation - Interim Analysis of the Amsterdam-Leiden-Groningen Randomized Controlled Trial
por: van Sandwijk, Marit S., et al.
Publicado: (2018)

Center-driven and Clinically Driven Variation in US Liver Transplant Maintenance Immunosuppression Therapy: A National Practice Patterns Analysis
por: Nazzal, Mustafa, et al.
Publicado: (2018)

HLA Homozygosity and Likelihood of Sensitization in Kidney Transplant Candidates
por: Rushakoff, Joshua A., et al.
Publicado: (2022)

The Association Between Broad Antigen HLA Mismatches, Eplet HLA Mismatches and Acute Rejection After Kidney Transplantation
por: Do Nguyen, Hung Thanh, et al.
Publicado: (2016)

Time to Move on: HLA Matching Should Be Reconsidered in Modern Deceased Donor Kidney Allocation
por: Gramlick, Madelyn E., et al.
Publicado: (2022)

Nonimmunologic Donor-Recipient Pairing, HLA Matching, and Graft Loss in Deceased Donor Kidney Transplantation
por: Vinson, Amanda Jean, et al.
Publicado: (2018)

Effect of Early Steroid Withdrawal on Posttransplant Diabetes Among Kidney Transplant Recipients Differs by Recipient Age
por: Ahn, JiYoon B., et al.
Publicado: (2021)

Effect of Maintaining Immunosuppression After Kidney Allograft Failure on Mortality and Retransplantation
por: Balakrishnan, Suryanarayanan, et al.
Publicado: (2022)

Cancer Risk Following HLA-Incompatible Living Donor Kidney Transplantation
por: Motter, Jennifer D., et al.
Publicado: (2023)

Low-dose Rituximab and Thymoglobulin Induction With Steroid-free Maintenance Immunosuppression and Protocol Biopsies Improves Long-term Patient and Graft Survival After Kidney Transplantation: Survival and Safety Outcomes in More Than 1100 Patients From a Single Center
por: Pathak, Vivek, et al.
Publicado: (2019)

Long-term Immunosuppression Adherence After Kidney Transplant and Relationship to Allograft Histology
por: Lorenz, Elizabeth C., et al.
Publicado: (2018)

Acute Rejection Phenotypes in the Current Era of Immunosuppression: A Single-Center Analysis
por: Wehmeier, Caroline, et al.
Publicado: (2017)

Preformed Donor-specific Antibodies Against HLA Class II and Graft Outcomes in Deceased-donor Kidney Transplantation
por: Uffing, Audrey, et al.
Publicado: (2019)

Impact of Subclinical and Clinical Kidney Allograft Rejection Within 1 Year Posttransplantation Among Compatible Transplant With Steroid Withdrawal Protocol
por: Owoyemi, Itunu, et al.
Publicado: (2021)

Clinical Implications of Tacrolimus Time in Therapeutic Range and Intrapatient Variability in Urban Renal Transplant Recipients Undergoing Early Corticosteroid Withdrawal
por: Pierce, Dana R., et al.
Publicado: (2021)

Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients
por: Tedesco-Silva, Helio, et al.
Publicado: (2016)

The Risk of Failure With HLA Mismatch and Recipient Age in First Pediatric (<18 years) Kidney Transplants
por: Williams, Robert C., et al.
Publicado: (2018)

Mycophenolate Monotherapy in HLA-Matched Kidney Transplant Recipients: A Case Series of 20 Patients
por: Hennes, Anthony J., et al.
Publicado: (2020)

Marginal Impact of Tocilizumab Monotherapy on Anti-HLA Alloantibodies in Highly Sensitized Kidney Transplant Candidates
por: Daligault, Mélanie, et al.
Publicado: (2021)

HLA Antibody Incompatible Renal Transplantation: Long-term Outcomes Similar to Deceased Donor Transplantation
por: Krishnan, Nithya, et al.
Publicado: (2021)

Robotic-assisted Kidney Transplantation With Simultaneous Bilateral Nephrectomies Is an Efficient, Feasible, and Safe Way to Manage Patients With Renal Failure Secondary to Adult Polycystic Kidney Disease
por: Rofaiel, George, et al.
Publicado: (2021)

Reliability and Validity of the Japanese Version of the Basel Assessment of Adherence to Immunosuppressive Medications Scale in Kidney Transplant Recipients
por: Kosoku, Akihiro, et al.
Publicado: (2023)

Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor–free, Belatacept Plus Everolimus–based Immunosuppression
por: Peddi, V. Ram, et al.
Publicado: (2023)

Class and Kinetics of Weakly Reactive Pretransplant Donor-specific HLA Antibodies Predict Rejection in Kidney Transplant Recipients
por: Morrison, Alexander H., et al.
Publicado: (2019)

The Risk of Transplant Failure With HLA Mismatch in First Adult Kidney Allografts 2: Living Donors, Summary, Guide
por: Williams, Robert C., et al.
Publicado: (2017)

Application of Operational Tolerance Signatures Are Limited by Variability and Type of Immunosuppression in Renal Transplant Recipients: A Cross-Sectional Study
por: Bottomley, Matthew J., et al.
Publicado: (2016)

The UK National Registry of ABO and HLA Antibody Incompatible Renal Transplantation: Pretransplant Factors Associated With Outcome in 879 Transplants
por: Pankhurst, Laura, et al.
Publicado: (2017)

HLA Alleles Cw12 and DQ4 in Kidney Transplant Recipients Are Independent Risk Factors for the Development of Posttransplantation Diabetes
por: Phagura, Nuvreen, et al.
Publicado: (2021)

Immunosuppression Adherence in Stable Kidney Transplant Patients Converted From Immediate- to Prolonged-Release Tacrolimus in Clinical Practice: A Norwegian Study
por: Abedini, Sadollah, et al.
Publicado: (2018)

Efficacy and Safety of a Tofacitinib-based Immunosuppressive Regimen After Kidney Transplantation: Results From a Long-term Extension Trial
por: Busque, Stephan, et al.
Publicado: (2018)

UNOS/OPTN Data-guided Assessment of Focal Segmental Glomerulosclerosis After Kidney Transplantation and Evaluation of Immunosuppressive Protocols in a Steroid-free Center
por: Kurian, Sunil M., et al.
Publicado: (2021)

Successful Kidney Transplantation After Stepwise Desensitization Using Rituximab and Bortezomib in a Highly HLA-Sensitized and ABO Incompatible High Titer Patient
por: Inui, Masashi, et al.
Publicado: (2016)

Long-term Prolonged-release Tacrolimus-based Immunosuppression in De Novo Kidney Transplant Recipients: 5-Y Prospective Follow-up of Patients in the ADVANCE Study
por: Pernin, Vincent, et al.
Publicado: (2023)

Comparison of the Immune Response After an Extended Primary Series of COVID-19 Vaccination in Kidney Transplant Recipients Receiving Standard Versus Mycophenolic Acid–sparing Immunosuppressive Regimen
por: Phirom, Supitchaya, et al.
Publicado: (2022)

HLA Matching Trumps Donor Age: Donor-Recipient Pairing Characteristics That Impact Long-Term Success in Living Donor Kidney Transplantation in the Era of Paired Kidney Exchange
por: Milner, John, et al.
Publicado: (2016)

One-year Outcome of Everolimus With Standard-dose Tacrolimus Immunosuppression in De Novo ABO-incompatible Living Donor Kidney Transplantation: A Retrospective, Single-center, Propensity Score Matching Comparison With Mycophenolate in 42 Transplants
por: Noguchi, Hiroshi, et al.
Publicado: (2019)

Three-year Outcomes After Conversion From Monthly to Every 2-month Belatacept Maintenance Therapy in Kidney Transplant Recipients: Results From a Randomized Controlled Trial
por: Johnson, Aileen C., et al.
Publicado: (2023)

The Tangible Benefits of Living Donation: Results of a Qualitative Study of Living Kidney Donors
por: Van Pilsum Rasmussen, Sarah E., et al.
Publicado: (2020)

Postdonation eGFR and New-Onset Antihypertensive Medication Use After Living Kidney Donation
por: Lentine, Krista L., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l6t2k8ts7sd2rm47kuhqtijbfh